Por favor, use este identificador para citar o enlazar este ítem:
https://doi.org/10.14670/HH-18-421
Twittear
Título: | Histopathological evaluation of insulin-DMSO formula designed for direct nose-to-brain delivery |
Fecha de publicación: | 2022 |
Editorial: | Universidad de Murcia, Departamento de Biologia Celular e Histiologia |
Cita bibliográfica: | Histology and Histopathology Vol. 37, nº5 (2022) |
ISSN: | 0213-3911 1699-5848 |
Materias relacionadas: | CDU::6 - Ciencias aplicadas::61 - Medicina::616 - Patología. Medicina clínica. Oncología |
Palabras clave: | Histopathology Insulin DMSO Alzheimer’s disease Nose-to-brain drug delivery Fluoresceine Sodium |
Resumen: | The combination of insulin and DMSO is a patented (Publication No US8987199B2), noninvasive, pharmaceutically strategized preparation for direct noseto-brain delivery (DN2BD) suggested for the treatment of Alzheimer’s disease (AD). Although its main ingredients have been individually researched, no histopathological investigations have been conducted to address this combination effect on the CNS and nasal tissues in animals. The present work was, therefore, designed to investigate the potential histopathological changes induced by this new pharmaceutical combination using a newly developed refractory staining method. The findings presented herein showed no signs of treatment-related lesions or behavioral changes in Sprague Dawley rats following a three-month successive treatment with two strengths of the formula. |
Autor/es principal/es: | Maher, Mustafa A. Kandeel, Wafaa A. Hammam, Olfat A. Attia, Yasmeen M. Mahmoud, Soheir Salah, Mohamed |
URI: | http://hdl.handle.net/10201/128544 |
DOI: | https://doi.org/10.14670/HH-18-421 |
Tipo de documento: | info:eu-repo/semantics/article |
Número páginas / Extensión: | 9 |
Derechos: | info:eu-repo/semantics/openAccess Attribution-NonCommercial-NoDerivatives 4.0 Internacional |
Aparece en las colecciones: | Vol.37, nº5 (2022) |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Maher-37-431-439-2022.pdf | 7,5 MB | Adobe PDF | Visualizar/Abrir |
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons